Nurse Practitioner, Adult Health · Amherst, NY
NPI
1962603316
Since 2007
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
760 Millersport Hwy
Amherst, NY, 14226
Phone (716) 446-1435
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
430 services
Medicare patients, 2024
100
Average age 60
Drug cost, 2024
$4.5M
3,097 prescriptions
Company payments, 2025
$583
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth L Tacca was code 99215 (office e&m - established), 118 times for 84 patients. In total Beth L Tacca billed 430 services in 9 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 118 | 84 | $107.95 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 73 | $10.47 | $984 |
By year: 2022 $40K for 360 services; 2023 $41K for 366 services; 2024 $38K for 430 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth L Tacca prescribed most often to Medicare patients was Baclofen, with 299 prescriptions and refills. In total Beth L Tacca wrote 3,097 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 299 | 446 | 66 | $6,367 |
| Gabapentin Generic | 264 | 402 | 55 | $5,630 |
| Teriflunomide Generic | 194 | 206 | 24 | $361K |
| Dalfampridine Er Dalfampridine | 147 | 190 | 28 | $103K |
| Avonex Pen (4 Pack) Interferon Beta-1a | 112 | 112 | 11 | $877K |
| Glatiramer Acetate Generic | 91 | 93 | 12 | $167K |
| Modafinil Generic | 89 | 101 | 19 | $3,601 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 78 | 92 | 14 | $2,915 |
| Avonex (4 Pack) Interferon Beta-1a | 71 | 76 | Under 11 | $621K |
| Pregabalin Generic | 71 | 87 | 13 | $3,337 |
| Tizanidine Hcl Generic | 70 | 106 | 15 | $1,399 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 69 | 77 | 13 | $3,106 |
| Amitriptyline Hcl Generic | 65 | 117 | 14 | $855 |
| Clonazepam Generic | 63 | 87 | 18 | $937 |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 61 | 63 | 14 | $2,152 |
Brand drugs: 470 claims; generic drugs: 2,627 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Beth L Tacca $583 ($583 in general payments such as food, travel and fees) from 7 companies. The largest payer was Genentech USA, Inc. with $213.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.